Muse MRgFUS study opens recruiting as early feasibility work moves forward — LiveFuture News
Open on LiveFuture.ai →

Muse MRgFUS study opens recruiting as early feasibility work moves forward

ClinicalTrials.gov lists the Muse Magnetic Resonance Guided Focused Ultrasound System study as EARLY_PHASE1 and RECRUITING, with safety, feasibility, and tolerability outcomes tracked over 2 months.

A new early-stage device study is now recruiting, and the practical takeaway is simple: the Muse Magnetic Resonance Guided Focused Ultrasound System is being tested for safety and feasibility before anyone can treat the study as proof of benefit. ClinicalTrials.gov lists the study as EARLY_PHASE1 and RECRUITING, with the University of Utah as sponsor.

The registry entry is dated 2026-11-20T00:00:00+00:00. It also gives an estimated primary completion date of 2027-01, which means the current update is an in-progress snapshot rather than a finished result.

What the study is testing

The study title is Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System. The intervention is the Muse MRgFUS System, listed as a DEVICE in a single experimental arm.

Its primary outcomes are centered on the frequency of adverse events, adverse device effects, and serious adverse events, each tracked by type, severity, seriousness, duration, and relationship to the investigational intervention over 2 months. In plain language, the study is asking whether the procedure can be carried out acceptably and what kinds of problems, if any, appear around the treatment.

Why readers should care

That matters because early feasibility studies are the first formal step in seeing whether a new treatment approach is workable. This one is framed around soft tissue ablation, subject-reported procedural pain, and device- and procedure-related safety signals, so the focus is on tolerability as much as on technique.

Because the record shows no results, nothing in the registry entry should be read as a verdict on success or failure. It is a recruiting study with a near-term estimated completion timeline, so the most honest reading is that this is an early test of whether the system can move ahead in a controlled way.

This record describes a study and its registry status; study outcomes require posted results. Source: ctgov_v2